6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
5m ago	ProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
6m ago	Parker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
6m ago	Toll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
6m ago	When Blood Compatibility Becomes a Pregnancy Risk
6m ago	Tony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference

About

211.32USD-0.98 -0.46%

Closed • Updated at 13:53 GMT+00:00

Market Cap$373.36B

P/E Ratio104.23

Volume138.9K

Beta-0.02

RSI55.17

Gross Margin70.58%

Health TechnologyPharmaceuticals: Major

Abbvie Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth

AbbVie to Present at the Bank of America Securities Healthcare Conference

AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®

SKYRIZI® (risankizumab) Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis

Adalimumab, Infliximab and Etanercept Biosimilars Trastuzumab Biosimilars Research Report 2026: $8.05 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035

Community Chat

Ask AI